Gabapentin significantly improves analgesia in people receiving opioids for neuropathic cancer pain
- 1 February 2005
- journal article
- editorial
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 31 (1) , 58-62
- https://doi.org/10.1016/j.ctrv.2004.12.001
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trialPAIN®, 2002
- Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled studyPublished by Wolters Kluwer Health ,2001
- An international survey of cancer pain characteristics and syndromesPain, 1999
- Gabapentin modifies extracellular opioid peptide content in amygdala: a microdialysis studyEpilepsy Research, 1999
- Assessment and treatment of neuropathic cancer pain following WHO guidelinesPain, 1999
- Gabapentin for the Treatment of Postherpetic NeuralgiaA Randomized Controlled TrialJAMA, 1998
- Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes MellitusA Randomized Controlled TrialJAMA, 1998
- Gabapentin enhances the antinociceptive effects of spinal morphine in the rat tail-flick testPain, 1997
- The visual analogue pain intensity scale: what is moderate pain in millimetres?Pain, 1997